Related Experiment Videos
What's new in cytostatic drug resistance and pathology
1Institute of Pathology, Christian-Albrechts-Universität, Kiel, FRG.
Abstract:
A major problem in cytostatic treatment of malignant tumors is the development of chemoresistant cell clones. An increased understanding of chemoresistance related mechanisms, improved methods for the detection and localization of resistant cell populations including predictive conclusions on the effectiveness of cytostatic drugs would contribute to the advancement of anti-tumor strategies. This paper reviews current concepts suggested for the development of cellular resistance to natural product drugs (anthracyclines, Vinca alkaloids, epipodophyllotoxines, antibiotics; so-called multidrug resistance substances), alkylating agents (nitrosureas, busulfan and mitomycin C), heavy metal compounds (cisplatin) and antifolates (5-fluorouracil, methotrexate) and describes the role of drug transporting and binding proteins (P-170-glycoprotein), detoxifying enzymes (glutathion-S-transferase, dihydrofolate reductase), DNA repair enzymes (topoisomerase I and II, polymerase alpha and beta), and genomic alterations (amplification, double minutes and homogeneous staining regions) due to resistance. It is focussed on the employment of morphological methods (light microscopy, immunocytochemistry, electron microscopy, fluorescence analysis, in situ hybridization, computer aided morphometric analysis) which will help to detect resistant cell clones in tumor biopsies. First correlations between histological data and clinical course will be reported. In the future, the morphological determination of chemoresistance may play an important role in applied functional tumor pathology.
Insights
Chemoresistant cancer cells pose a major challenge in cytostatic treatment. This review explores mechanisms of chemoresistance and morphological methods for detecting resistant tumor cells to improve anti-tumor strategies.
Area of Science:
- Oncology
- Cell Biology
- Pathology
Background:
- Chemoresistance in malignant tumors is a significant clinical problem, hindering effective cytostatic treatment.
- Understanding chemoresistance mechanisms is crucial for developing improved anti-tumor strategies and predicting drug efficacy.
Purpose of the Study:
- To review current concepts on cellular chemoresistance mechanisms.
- To highlight morphological methods for detecting chemoresistant cell clones in tumor biopsies.
Main Methods:
- Review of literature on chemoresistance mechanisms and detection methods.
- Focus on morphological techniques including light microscopy, immunocytochemistry, electron microscopy, fluorescence analysis, in situ hybridization, and computer-aided morphometric analysis.
Main Results:
- Chemoresistance involves drug transporters (P-170-glycoprotein), detoxifying enzymes (glutathione-S-transferase), DNA repair enzymes (topoisomerase), and genomic alterations.
- Morphological methods can detect chemoresistant cell clones in tumor biopsies.
Conclusions:
- Morphological determination of chemoresistance shows promise for applied functional tumor pathology.
- Improved detection of chemoresistant cells can guide treatment decisions and enhance anti-tumor strategies.